Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities
Net loss	$ (23,958)	$ (22,956)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	42,663	40,570
Amortization of deferred financing costs	2,465	1,749
Credit loss expense (reversal), net	8,149	(4,884)
Write-downs	5,707	878
Deferred income tax benefit	(3,374)	(1,687)
Share-based and other non-cash compensation	19,510	18,558
Unrealized foreign currency exchange loss	1,310	555
Realized and unrealized investment gains	(99)	(5,311)
Changes in assets and liabilities:
Accounts receivable	(18,050)	(24,336)
Inventories	(10,131)	653
Film assets	(14,174)	(10,035)
Deferred revenue	(5,989)	(1,434)
Changes in other operating assets and liabilities	(3,548)	(11,902)
Net cash provided by (used in) operating activities	481	(19,582)
Investing Activities
Acquisition of SSIMWAVE, net of cash and cash equivalents acquired	(12,639)
Purchase of property, plant and equipment	(5,248)	(2,353)
Investment in equipment for joint revenue sharing arrangements	(14,543)	(5,361)
interest in film classified as a financial instrument	(4,731)
Acquisition of other intangible assets	(3,246)	(3,399)
Proceeds from sale of equity securities		17,769
Net cash (used in) provided by investing activities	(40,407)	6,656
Financing Activities
Proceeds from issuance of convertible notes, net		223,675
Debt issuance costs related to convertible notes		(1,163)
Purchase of capped calls related to convertible notes		(19,067)
Revolving credit facility borrowings	4,890	3,600
Repayments of revolving credit facility borrowings	(3,600)	(300,243)
Credit facility amendment fees paid	(2,277)	(474)
Taxes withheld and paid on employee stock awards vested	(3,393)	(3,045)
Common shares issued - stock options exercised		883
Principal payment under finance lease obligations	(890)
Dividends paid to non-controlling interests	(2,701)	(5,027)
Net cash used in financing activities	(64,595)	(110,487)
Effects of exchange rate changes on cash and cash equivalents	1,961	(958)
Decrease in cash and cash equivalents during period	(102,560)	(124,371)
Cash and cash equivalents, beginning of period	189,711	317,379
Cash and cash equivalents, end of period	87,151	193,008
IMAX Corporation
Financing Activities
Repurchase of common shares	(53,581)	(4,610)
IMAX China
Financing Activities
Repurchase of common shares	$ (3,043)	$ (5,016)